跳至主要内容
临床试验/NL-OMON53021
NL-OMON53021招募中3 期

Mesenteric Sparing versus more extended mesenterectomy in Ileocolic Resection for ileocecal Crohn*s Disease - SPICY trial

Academisch Medisch Centrum0 个研究点目标入组 118 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
118

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 至 99(—)

入选标准

  • 11) Males and females aged >16 years,
  • 2) Ileo(colic) disease with an indication for primary ileocaecal - or ileocolic
  • 3) All concurrent therapies are permitted,
  • 4) All patients should have terminal ileitis (L1 or L3 disease), previously
  • confirmed during endoscopy, with a recent update (<= 3 months) of imaging (e.g.
  • ultrasound, MR, CT enterography) before confirmation eligibility, preferably
  • discussed in MDT,
  • 5) ability to comply with protocol,
  • 6) competent and able to provide written informed consent.

排除标准

  • 1. Inability to give informed consent.
  • 2. patients less than 16 years of age.
  • 3. Patients undergoing repeated ileocolic resection.
  • 4. Clinically significant medical conditions within the six months before the
  • operation : e.g. myocardial infarction, active angina, congestive heart failure
  • or other conditions that would, in the opinion of the investigators, compromise
  • the safety of the patient.
  • 5. History of cancer < 5 years which might influence patients prognosis
  • 6. Emergent operation.
  • 7. Pregnant or breast feeding.
  • 8. Inability to follow up at 3, 6 and 12 months for postoperative assessment,
  • imaging and endoscopy.

研究者

相似试验

Mesenteric Sparing versus more extended... | 临床试验